Biotech Layoffs San Diego. Yet biopharma layoff trends have remained high. In 2016, biosplice, then known as samumed, made headlines by raising $220 million at a $6 billion valuation;

Bristol myers squibb plans to lay off 252 employees at a mirati therapeutics site in san diego in late april, according to a california worker adjustment and retraining. Yet biopharma layoff trends have remained high.